Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
All protocols, dosages, and treatment insights referenced herein are based on published literature
AOD 9604 long-term outlook The long-term safety data for AOD 9604 is limited because the clinical development program was terminated
AHK-Cu emerged later as researchers explored variations on the original copper-binding tripeptide structure, swapping the glycine residue for alanine to see how the change affected biological activity
After the injection regimen, no further medication was given
US$ 29.89
US$ 26.90
US$ 20.92
US$ 27.90
US$ 25.91
US$ 24.49
